Logo image of IRBT

IROBOT CORP (IRBT) Stock Fundamental Analysis

NASDAQ:IRBT - Nasdaq - US4627261005 - Common Stock - Currency: USD

3.96  -0.25 (-5.94%)

Premarket: 4.03 +0.07 (+1.77%)

Fundamental Rating

1

Taking everything into account, IRBT scores 1 out of 10 in our fundamental rating. IRBT was compared to 63 industry peers in the Household Durables industry. IRBT has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, IRBT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

IRBT had negative earnings in the past year.
In the past year IRBT has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: IRBT reported negative net income in multiple years.
IRBT had negative operating cash flow in 4 of the past 5 years.
IRBT Yearly Net Income VS EBIT VS OCF VS FCFIRBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M -300M

1.2 Ratios

Looking at the Return On Assets, with a value of -52.31%, IRBT is doing worse than 95.24% of the companies in the same industry.
Industry RankSector Rank
ROA -52.31%
ROE N/A
ROIC N/A
ROA(3y)-34.67%
ROA(5y)-17.81%
ROE(3y)-150.96%
ROE(5y)-86.07%
ROIC(3y)N/A
ROIC(5y)N/A
IRBT Yearly ROA, ROE, ROICIRBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

With a Gross Margin value of 21.06%, IRBT is not doing good in the industry: 73.02% of the companies in the same industry are doing better.
IRBT's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for IRBT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.94%
GM growth 5Y-13.55%
IRBT Yearly Profit, Operating, Gross MarginsIRBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

0

2. Health

2.1 Basic Checks

IRBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IRBT has more shares outstanding
The number of shares outstanding for IRBT has been increased compared to 5 years ago.
The debt/assets ratio for IRBT is higher compared to a year ago.
IRBT Yearly Shares OutstandingIRBT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
IRBT Yearly Total Debt VS Total AssetsIRBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -0.95, we must say that IRBT is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.95, IRBT is doing worse than 87.30% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.95
ROIC/WACCN/A
WACC10.87%
IRBT Yearly LT Debt VS Equity VS FCFIRBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 0.55 indicates that IRBT may have some problems paying its short term obligations.
With a Current ratio value of 0.55, IRBT is not doing good in the industry: 96.83% of the companies in the same industry are doing better.
IRBT has a Quick Ratio of 0.55. This is a bad value and indicates that IRBT is not financially healthy enough and could expect problems in meeting its short term obligations.
IRBT has a worse Quick ratio (0.39) than 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 0.55
Quick Ratio 0.39
IRBT Yearly Current Assets VS Current LiabilitesIRBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

4

3. Growth

3.1 Past

IRBT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.74%, which is quite impressive.
The Revenue for IRBT has decreased by -28.05% in the past year. This is quite bad
Measured over the past years, IRBT shows a very negative growth in Revenue. The Revenue has been decreasing by -10.90% on average per year.
EPS 1Y (TTM)21.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.45%
Revenue 1Y (TTM)-28.05%
Revenue growth 3Y-24.19%
Revenue growth 5Y-10.9%
Sales Q2Q%-32.29%

3.2 Future

IRBT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 33.34% yearly.
IRBT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.89% yearly.
EPS Next Y50.57%
EPS Next 2Y33.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-25.12%
Revenue Next 2Y9.89%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IRBT Yearly Revenue VS EstimatesIRBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
IRBT Yearly EPS VS EstimatesIRBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 4 -4 -6 -8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

IRBT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year IRBT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IRBT Price Earnings VS Forward Price EarningsIRBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IRBT Per share dataIRBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

A more expensive valuation may be justified as IRBT's earnings are expected to grow with 33.34% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.34%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for IRBT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IROBOT CORP

NASDAQ:IRBT (8/1/2025, 8:00:02 PM)

Premarket: 4.03 +0.07 (+1.77%)

3.96

-0.25 (-5.94%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)08-04 2025-08-04
Inst Owners54.73%
Inst Owner Change0.55%
Ins Owners1.51%
Ins Owner Change24.23%
Market Cap123.20M
Analysts45.71
Price Target11.22 (183.33%)
Short Float %26.12%
Short Ratio2.61
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-33.81%
Min EPS beat(2)-50.53%
Max EPS beat(2)-17.08%
EPS beat(4)1
Avg EPS beat(4)19.02%
Min EPS beat(4)-50.53%
Max EPS beat(4)152.06%
EPS beat(8)4
Avg EPS beat(8)7.13%
EPS beat(12)5
Avg EPS beat(12)-79.21%
EPS beat(16)7
Avg EPS beat(16)-49.56%
Revenue beat(2)0
Avg Revenue beat(2)-13.54%
Min Revenue beat(2)-20.34%
Max Revenue beat(2)-6.73%
Revenue beat(4)0
Avg Revenue beat(4)-10.93%
Min Revenue beat(4)-20.34%
Max Revenue beat(4)-3.48%
Revenue beat(8)2
Avg Revenue beat(8)-8.48%
Revenue beat(12)2
Avg Revenue beat(12)-13.48%
Revenue beat(16)4
Avg Revenue beat(16)-10.35%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.75%
EPS NY rev (1m)0%
EPS NY rev (3m)-42.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.41%
Revenue NY rev (1m)-20.07%
Revenue NY rev (3m)-23.59%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.19
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-5.94
EYN/A
EPS(NY)-1.23
Fwd EYN/A
FCF(TTM)-1.96
FCFYN/A
OCF(TTM)-1.96
OCFYN/A
SpS20.36
BVpS-0.03
TBVpS-5.64
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -52.31%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.06%
FCFM N/A
ROA(3y)-34.67%
ROA(5y)-17.81%
ROE(3y)-150.96%
ROE(5y)-86.07%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.94%
GM growth 5Y-13.55%
F-Score2
Asset Turnover1.37
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.55
Quick Ratio 0.39
Altman-Z -0.95
F-Score2
WACC10.87%
ROIC/WACCN/A
Cap/Depr(3y)11.65%
Cap/Depr(5y)43.11%
Cap/Sales(3y)0.46%
Cap/Sales(5y)1.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.45%
EPS Next Y50.57%
EPS Next 2Y33.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-28.05%
Revenue growth 3Y-24.19%
Revenue growth 5Y-10.9%
Sales Q2Q%-32.29%
Revenue Next Year-25.12%
Revenue Next 2Y9.89%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year117.97%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y34.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y25.65%
OCF growth 3YN/A
OCF growth 5YN/A